SCHEMBL223704

SCHEMBL223704

O=[N+]([O-])c1ccc(OP(=O)(O)Oc2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 1.00
CES2 O00748 1/20 1.00
CA1 P00915 4/20 0.79
CA2 P00918 3/20 0.79
BCHE P06276 1/20 0.57
ACHE P22303 1/20 0.57
MAPK1 P28482 3/20 0.56
ALDH1A1 P00352 2/20 0.56
CYP3A4 P08684 2/20 0.56
HSD17B10 Q99714 2/20 0.56
AKR1C3 P42330 1/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
THRB P10828 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
TSHR P16473 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HSPB1 P04792 1/20 0.48
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11588705 0.98 CES1 (0.96) CES1CES2CA1CA2BCHE
Water SCHEMBL9045475 0.98 CES1 (0.96) CES1CES2CA1CA2BCHE
SCHEMBL11588711 0.98 CES1 (0.96) CES1CES2CA1CA2BCHE
Bromide SCHEMBL11420868 0.98 CES1 (0.96) CES1CES2CA1CA2BCHE
SCHEMBL5246741 0.93 CES1 (0.86) CES1CES2CA1CA2BCHE
SCHEMBL233887 0.93 CES2 (0.86) CES1CES2CA1CA2BCHE
Pyrophosphoric Acid SCHEMBL29033361 0.93 CES1 (0.86) CES1CES2CA1CA2BCHE
SCHEMBL609222 0.91 CES1 (0.83) CES1CES2CA1CA2BCHE
SCHEMBL5246747 0.90 CES2 (0.81) CES1CES2CA1CA2BCHE
SCHEMBL4823833 0.89 CES2 (0.80) CES1CES2CA1CA2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1037 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035753-A1 METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO KEMIRA OYJ (FI) 2026-02-05 US claimed
CN-119008962-B Preparation method and application of high-binding-force current collector 江阴纳力新材料科技有限公司 2025-06-10 CN claimed
US-12297597-B2 Cellulose composition KEMIRA OYJ (FI) 2025-05-13 US claimed
CN-119798023-A Synthesis method of high-purity high laurene 万华化学集团股份有限公司 2025-04-11 CN claimed
CN-119514147-A Land ecological system overground and underground net primary productivity estimation method and system 武汉大学 2025-02-25 CN claimed
WO-2025007970-A1 REGENERATION TREATMENT METHOD FOR DEGRADABLE HIGH POLYMER MATERIAL AND USE 复旦大学 2025-01-09 WO claimed
CN-119263974-A Regeneration treatment method and application of degradable high polymer material 复旦大学 2025-01-07 CN claimed
CN-119008962-A Preparation method and application of high-binding-force current collector 江阴纳力新材料科技有限公司 2024-11-22 CN claimed
CN-118591343-A Skin patch for collecting physiological samples 萨蒂奥股份有限公司 2024-09-03 CN claimed
CN-115872820-B Method for synthesizing chiral 2-functionalized tetrahydroquinoline through biomimetic catalysis and asymmetric hydrogenation 中国科学院大连化学物理研究所 2024-08-06 CN claimed
US-20090117603-A1 STERILIZATION INDICATOR FRANCISKOVICH PHILLIP P 2009-05-07 US claimed
WO-2008082728-A2 STERILIZATION INDICATOR AMERICAN STERILIZER COMPANY (US) 2008-07-10 WO claimed
WO-2008079469-A2 GENETICALLY ENGINEERED BIOLOGICAL INDICATOR AMERICAN STERILIZER COMPANY (US) 2008-07-03 WO claimed
US-20080070231-A1 Reporter genes taken up by microorganism, and repressor gene inhibits expression AMERICAN STERILIZER COMPANY 2008-03-20 US claimed
US-20080070272-A1 STERILIZATION INDICATOR AMERICAN STERILIZER COMPANY 2008-03-20 US claimed
US-20050181473-A1 Bacterial adpglucose pyrophospatase method for obtaining the latter and its use in the production of assay devices and in the obtention of transgenic plants and bacteria UNIVERSIDAD PUBLICA DE NAVARRA (ES) 2005-08-18 US claimed
EP-1378567-A1 BACTERIAL ADPGLUCOSE PYROPHOSPHATASE, METHOD FOR OBTAINING THE LATTER AND ITS USE IN THE PRODUCTION OF ASSAY DEVICES AND IN THE OBTENTION OF TRANSGENIC PLANTS AND BACTERIA UNIVERSIDAD PUBLICA DE NAVARRA (ES) 2004-01-07 EP claimed
EP-1238099-A2 AUTOMATED LYSOPHOSPHOLIPID ASSAY AND METHODS OF DETECTING CANCER ABBOTT LABORATORIES (US) 2002-09-11 EP claimed
WO-2001032916-A2 AUTOMATED LYSOPHOSPHOLIPID ASSAY AND METHODS OF DETECTING CANCER ABBOTT LABORATORIES (US) 2001-05-10 WO claimed
WO-1996040704-A1 PYRAZOLE-RELATED DERIVATIVES ENDOWED WITH ANTITUMOR AND ANTIVIRAL ACTIVITIES, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM SARDINIAN ANTIVIRAL RESEARCH CONSORTIUM SARC S.C.R.L. (IT) 1996-12-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035753-A1 METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO POLL, UROD, RNGTT CES1 1312/4885CES2 1554/4885CA1 3423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.